Targeting Epstein–Barr virus is a viable therapeutic strategy in multiple sclerosis: Yes

Multiple Sclerosis Journal 2026

View at publisher

Authors: Lawrence Steinman

DOI: 10.1177/13524585251409964

Cited by: 0

References: 8

Fields of Study & Subjects

Multiple Sclerosis Research Studies Viral-associated cancers and disorders Cytomegalovirus and herpesvirus research

References 8